Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study

Despite the availability of effective therapies, most gout patients achieve suboptimal treatment outcomes. Current best practices suggest gradual dose-escalation of urate lowering therapy and serial serum urate (sUA) measurement to achieve sUA

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Contemporary clinical trials 2016-09, Vol.50, p.106-115
Hauptverfasser:	Coburn, Brian W., Cheetham, T. Craig, Rashid, Nazia, Chang, John M., Levy, Gerald D., Kerimian, Artak, Low, Kimberly J., Redden, David T., Bridges, S. Louis, Saag, Kenneth G., Curtis, Jeffrey R., Mikuls, Ted R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Allopurinol Allopurinol - therapeutic use Ambulatory Care - organization & administration Automation Dose titration Gout Gout - blood Gout - drug therapy Gout Suppressants - therapeutic use Humans Patient Education as Topic Pharmacists - organization & administration Randomized trial Research Design Serum urate Telephone Uric Acid - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Despite the availability of effective therapies, most gout patients achieve suboptimal treatment outcomes. Current best practices suggest gradual dose-escalation of urate lowering therapy and serial serum urate (sUA) measurement to achieve sUA
ISSN:	1551-7144 1559-2030
DOI:	10.1016/j.cct.2016.07.019